White label ELPA - ClinicalTrials.eu

Study of SPI-62 for Treating Cushing’s Syndrome in Patients with Benign Adrenal Tumors

Not recruiting

2 1 1
Investigated diseases:
- Hyperadrenocorticism
Investigated drugs:
- 4-{5-[2-(4-Chloro-2,6-Difluorophenoxy)Propan-2-Yl]-4-Methyl-4H-1,2,4-Triazol-3-Yl}-3-Fluorobenzamide
Study to Evaluate Plozasiran for Adults with High Triglycerides

Not recruiting

3 1
Investigated diseases:
- Hypertriglyceridaemia
Investigated drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+3
Study of Mitapivat for Patients with Sickle Cell Disease and Kidney Disease

Not recruiting

2 1 1
Investigated diseases:
- Sickle cell disease
Investigated drugs:
- Mitapivat
Study on Long-term Safety of Satoreotide Tetraxetan Lutetium-177 for Patients with Somatostatin Receptor Positive Neuroendocrine Tumors

Not recruiting

3 1 1
Investigated diseases:
- Neuroendocrine tumour
Investigated drugs:
- Satoreotide Tetraxetan
- Satoreotide Tetraxetan Lutetium-177
Study on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation

Not recruiting

1 1 1 1
Investigated drugs:
- Azacitidine
- Venetoclax
Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Follicular lymphoma
- Diffuse large B-cell lymphoma
Investigated drugs:
Study on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy

Not recruiting

4 1
Investigated diseases:
- Idiopathic generalised epilepsy
Investigated drugs:
- Bhv-7000
+5
Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Not recruiting

2 1 1
Investigated diseases:
- Systemic lupus erythematosus
Investigated drugs:
- Obexelimab
- Betamethasone Sodium Phosphate
+4
Study of Pembrolizumab and 68GA-PSMA HBED-CC in Patients with High-Risk Prostate Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- 2-[[5-[3-[[6-[[(5S)-5-Carboxy-5-[[(1S)-1,3-Dicarboxypropyl]Carbamoylamino]Pentyl]Amino]-6-Oxohexyl]Amino]-3-Oxopropyl]-2-Oxidophenyl]Methyl-[2-[[5-(2-Carboxyethyl)-2-Oxidophenyl]Methyl-(Carboxylatomethyl)Amino]Ethyl]Amino]Acetate:gallium-68(3+) Hydron
- Pembrolizumab
Study of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma

Not recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies